Metaorganismal nutrient metabolism as a basis of cardiovascular disease

Current Opinion in Lipidology

Volumn 25, Issue 1, 2014, Pages 48-53

  Brown, J Mark ^a   Hazen, Stanley L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

atherosclerosis; cholesterol; L carnitine; trimethylamine; trimethylamineoxide

Indexed keywords

CARNITINE; CHOLINE; PHOSPHATIDYLCHOLINE; TRIMETHYLAMINE OXIDE;

AMINO ACID METABOLISM; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIETARY INTAKE; HUMAN; INTESTINE FLORA; METABOLOMICS; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; REVIEW;

MUS;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CARNITINE; DIET; HUMANS; METHYLAMINES; RISK;

EID: 84893001052     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000036     Document Type: Review

References (42)

1. Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: A systematic review and meta-analysis. Circulation 2010; 121:2271-2283.
2. Bernstein AM, Sun Q, Hu FB, et al. Major dietary protein sources and risk of coronary heart disease in women. Circulation 2010; 122:876-883.
3. Lichtenstein AH, Kennedy E, Barrier P, et al. Dietary fat consumption and health. Nutr Rev 1998; 56:S3-S19.
4. Steinberg D. Thematic review series: The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: Part II: The early evidence linking hypercholesterolemia to coronary disease in humans. J Lipid Res 2005; 46:179-190.
5. Möbius KA. Die Auster und dieAusternwirthschaft. Berlin: Wiegandt, Hempel & Parey; 1877.
6. Bell G. Model metaorganism. A review by Graham Bell. Science 1998; 282:248.
7. Biaga E, Candela M, Fairweather-Tait S, et al. Ageing of the human metaorganism: The microbial counterpart. Age 2011; 34:247-267.
8. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 2007; 449:804-810.
9. Goodman AL, Gordon JI. Our unindicted coconspirators: Human metabolism from a microbial perspective. Cell Metab 2010; 12:111-116.
10. Backhead F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101: 15718-15723.
11. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-1031.
12. Backhead F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007; 104:979-984.
13. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457:480-484.
14. Ley RE, Backhead F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102:11070-11075.
15. Velagapudi VR, Hezaveh R, Reigstad CS, et al. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res 2010; 51:1101-1112.
16. Samuel BS, Shaito A, Motoike T, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty acid binding G proteincoupled receptor, Gpr41. Proc Natl Acad Sci U S A 2008; 105:16767-16772.
17. Turnbaugh PJ, Backhead F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3:213-223.
18. Dumas ME, Barton RH, Toye A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 2006; 103:12511-12516.
19. Delzenne NM, Cani PD. Gut microbiota and the pathogenesis of insulin resistance. Curr Diab Rep 2011; 11:154-159.
20. Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. (2013) Gut microbiota and nonalcoholic fatty liver disease: New insights. Clin Microbiol Infect 2013; 19:338-348.
21. Griffin JL, Scott J, Nicholson JK. The influence of pharmacogenetics on fatty liver disease in the Wistar and Kyoto rats: A combined transcriptomic and metabonomic study. J Proteome Res 2007; 6:54-61.
22. Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499:97-101.
23. Ray K. Gut microbiota: Colorectal cancer-driven by inflammation and gut bacteria. Nat Rev Gastroenterol Hepatol 2012; 9:588.
24. Sjögren K, Engdahl C, Henning P, et al. The gut microbiota regulates bone mass in mice. J Bone Miner Res 2012; 27:1357-1367.
25. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472:57-6
26. Koeth RA, Wang Z, Levinson BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013; 19:576-58
27. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368:1575-158
28. Shah SH, Kraus WE, Newgard CB. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: Form and function. Circulation 2012; 126:1110-1120.
29. Brown HA. Lipidomics: When apocrypha becomes canonical. Curr Opin Chem Biol 2012; 16:221-226.
30. Lewington S, Whitlock G, Clarke R, et al., Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 2007; 370:1829-1839.
31. Lewis GD, Wei R, Liu E, et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 2008; 118:3503-3512.
32. Yancey PH, Clark ME, Hand SC, et al. Living with water stress: Evolution of osmolyte systems. Science 1982; 217:1214-1222.
33. Lin TY, Timasheff SN. Why do some organisms use a urea-methylamine mixture as osmolyte? Thermodynamic compensation of urea and trimethylamine N-oxide interactions with protein. Biochemistry 1994; 33:12695-12701.
34. Busby MG, Fischer L, da Costa KA, et al. Choline- and betaine-defined diets for use in clinical research and for the management of trimethylaminuria. J Am Diet Assoc 2004; 104:1836-1845.
35. Martin FP, Wang Y, Sprenger N, et al. Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model. Mol Sys Biol 2008; 4:1-17.
36. Cashman Jr. Role of flavin-monooxygenase in drug development. ExpertOpin Drug Metab Toxicol 2008; 4:1507-1521.
37. Motika MS, Zhang J, Cashman Jr. Flavin-containing monooxygenase 3 and human disease. Expert Opin Drug Metab Toxicol 2007; 3:831-845.
38. Yamazaki H, Shimizu M. Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities. Biochem Pharmacol 2013; 85:1588-1593.
39. Cashman Jr. Structural and catalytic properties of the mammalian flavincontaining monooxygenase. Chem Res Toxicol 1995; 8:166-181.
40. Bennett BJ, de Aguiar Vallim TQ, Wang Z, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab 2013; 17:49-6
41. Zhang J, Chaluvadi MR, Reddy R, et al. Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models. Drug Metab Dispos 2009; 37:462-468.
42. Coecke S, Debast G, Phillips IR, et al. Hormonal regulation of microsomal flavin-containing monooxygenase activity by sex steroids and growth hormone in co-cultured adult male rat hepatocytes. Biochem Pharmacol 1998; 56:1047-1051.